These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 30287485)

  • 1. Integrative genomic analysis of mouse and human hepatocellular carcinoma.
    Dow M; Pyke RM; Tsui BY; Alexandrov LB; Nakagawa H; Taniguchi K; Seki E; Harismendy O; Shalapour S; Karin M; Carter H; Font-Burgada J
    Proc Natl Acad Sci U S A; 2018 Oct; 115(42):E9879-E9888. PubMed ID: 30287485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents.
    Moeini A; Torrecilla S; Tovar V; Montironi C; Andreu-Oller C; Peix J; Higuera M; Pfister D; Ramadori P; Pinyol R; Solé M; Heikenwälder M; Friedman SL; Sia D; Llovet JM
    Gastroenterology; 2019 Nov; 157(5):1383-1397.e11. PubMed ID: 31344396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of HCC Mouse Models: Towards an Etiology-Oriented Subtyping Approach.
    Friemel J; Frick L; Unger K; Egger M; Parrotta R; Böge YT; Adili A; Karin M; Luedde T; Heikenwalder M; Weber A
    Mol Cancer Res; 2019 Jul; 17(7):1493-1502. PubMed ID: 30967480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated Genomic Comparison of Mouse Models Reveals Their Clinical Resemblance to Human Liver Cancer.
    Yim SY; Shim JJ; Shin JH; Jeong YS; Kang SH; Kim SB; Eun YG; Lee DJ; Conner EA; Factor VM; Moore DD; Johnson RL; Thorgeirsson SS; Lee JS
    Mol Cancer Res; 2018 Nov; 16(11):1713-1723. PubMed ID: 30082483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational landscape of a chemically-induced mouse model of liver cancer.
    Connor F; Rayner TF; Aitken SJ; Feig C; Lukk M; Santoyo-Lopez J; Odom DT
    J Hepatol; 2018 Oct; 69(4):840-850. PubMed ID: 29958939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of hepatocarcinogenesis using mouse models.
    Teoh WW; Xie M; Vijayaraghavan A; Yaligar J; Tong WM; Goh LK; Sabapathy K
    Dis Model Mech; 2015 Jul; 8(7):743-53. PubMed ID: 26035378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
    Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
    J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of SOCS1 and SOCS3 tumor suppressors and oncogenic signaling pathway genes in hepatocellular carcinoma.
    Khan MGM; Ghosh A; Variya B; Santharam MA; Ihsan AU; Ramanathan S; Ilangumaran S
    BMC Cancer; 2020 Aug; 20(1):774. PubMed ID: 32807134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features.
    Zhu C; Ho YJ; Salomao MA; Dapito DH; Bartolome A; Schwabe RF; Lee JS; Lowe SW; Pajvani UB
    J Hepatol; 2021 Mar; 74(3):613-626. PubMed ID: 33038431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A signature of six genes highlights defects on cell growth and specific metabolic pathways in murine and human hepatocellular carcinoma.
    Schröder PC; Segura V; Riezu JI; Sangro B; Mato JM; Prieto J; Santamaría E; Corrales FJ
    Funct Integr Genomics; 2011 Sep; 11(3):419-29. PubMed ID: 21562899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive molecular and immunological characterization of hepatocellular carcinoma.
    Shimada S; Mogushi K; Akiyama Y; Furuyama T; Watanabe S; Ogura T; Ogawa K; Ono H; Mitsunori Y; Ban D; Kudo A; Arii S; Tanabe M; Wands JR; Tanaka S
    EBioMedicine; 2019 Feb; 40():457-470. PubMed ID: 30598371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of bone marrow-derived cells in the origin of liver cancer revealed by single-cell sequencing.
    Chen L; Yi X; Guo P; Guo H; Chen Z; Hou C; Qi L; Wang Y; Li C; Liu P; Liu Y; Xu Y; Zhang N
    Cancer Biol Med; 2020 Feb; 17(1):142-153. PubMed ID: 32296582
    [No Abstract]   [Full Text] [Related]  

  • 13. Genomic Analysis of Vascular Invasion in HCC Reveals Molecular Drivers and Predictive Biomarkers.
    Krishnan MS; Rajan Kd A; Park J; Arjunan V; Garcia Marques FJ; Bermudez A; Girvan OA; Hoang NS; Yin J; Nguyen MH; Kothary N; Pitteri S; Felsher DW; Dhanasekaran R
    Hepatology; 2021 Jun; 73(6):2342-2360. PubMed ID: 33140851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic mutations and dysregulated pathways in obesity-associated hepatocellular carcinoma.
    Shen J; Tsoi H; Liang Q; Chu ES; Liu D; Yu AC; Chan TF; Li X; Sung JJ; Wong VW; Yu J
    Oncogene; 2016 Dec; 35(49):6271-6280. PubMed ID: 27132506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical implications of G1-G6 transcriptomic signature and 5-gene score in Korean patients with hepatocellular carcinoma.
    Ahn SM; Haq F; Park I; Nault JC; Zucman-Rossi J; Yu E
    BMC Cancer; 2018 May; 18(1):571. PubMed ID: 29776391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma.
    Joseph NM; Tsokos CG; Umetsu SE; Shain AH; Kelley RK; Onodera C; Bowman S; Talevich E; Ferrell LD; Kakar S; Krings G
    J Pathol; 2019 Jun; 248(2):164-178. PubMed ID: 30690729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse models of hepatocellular carcinoma.
    Fausto N; Campbell JS
    Semin Liver Dis; 2010 Feb; 30(1):87-98. PubMed ID: 20175036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative and comparative genomics analysis of early hepatocellular carcinoma differentiated from liver regeneration in young and old.
    Colak D; Chishti MA; Al-Bakheet AB; Al-Qahtani A; Shoukri MM; Goyns MH; Ozand PT; Quackenbush J; Park BH; Kaya N
    Mol Cancer; 2010 Jun; 9():146. PubMed ID: 20540791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
    Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
    Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcript profiling identifies iqgap2(-/-) mouse as a model for advanced human hepatocellular carcinoma.
    Gnatenko DV; Xu X; Zhu W; Schmidt VA
    PLoS One; 2013; 8(8):e71826. PubMed ID: 23951254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.